Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1995 1
1996 1
1997 1
1998 1
2005 4
2006 5
2007 9
2008 12
2009 9
2010 3
2011 9
2012 6
2013 7
2014 6
2015 16
2016 14
2017 19
2018 18
2019 14
2020 15
2021 13
2022 17
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Diabetic macular edema: Evidence-based management.
Browning DJ, Stewart MW, Lee C. Browning DJ, et al. Indian J Ophthalmol. 2018 Dec;66(12):1736-1750. doi: 10.4103/ijo.IJO_1240_18. Indian J Ophthalmol. 2018. PMID: 30451174 Free PMC article. Review.
Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 diabetes mellitus. ...
Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevale …
Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement system.
Bakri SJ, Bektas M, Sharp D, Luo R, Sarda SP, Khan S. Bakri SJ, et al. J Manag Care Spec Pharm. 2023 May;29(5-a Suppl):S2-S11. doi: 10.18553/jmcp.2023.29.5-a.s2. J Manag Care Spec Pharm. 2023. PMID: 37125931 Free PMC article.
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD), characterized by atrophic lesions that first start in the outer retina and progressively expand to cover the macula and the fovea, the center of the macula, leading to irreversibl …
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD), characterized by atrophic lesions that …
Paraproteinemic maculopathy.
Mansour AM, Arevalo JF, Badal J, Moorthy RS, Shah GK, Zegarra H, Pulido JS, Charbaji A, Amselem L, Lavaque AJ, Casella A, Ahmad B, Paschall JG, Caimi A, Staurenghi G. Mansour AM, et al. Ophthalmology. 2014 Oct;121(10):1925-32. doi: 10.1016/j.ophtha.2014.04.007. Epub 2014 Jun 18. Ophthalmology. 2014. PMID: 24950591
PURPOSE: Paraproteinemia relates to monoclonal gammopathy-producing pathologic antibodies with serous macular detachment being an uncommon ocular manifestation. We ascertained the clinical course of maculopathy in paraproteinemia and investigated the effect of various ther …
PURPOSE: Paraproteinemia relates to monoclonal gammopathy-producing pathologic antibodies with serous macular detachment being an unc …
Metabolic syndrome and the aging retina.
Roddy GW. Roddy GW. Curr Opin Ophthalmol. 2021 May 1;32(3):280-287. doi: 10.1097/ICU.0000000000000747. Curr Opin Ophthalmol. 2021. PMID: 33630786 Review.
PURPOSE OF REVIEW: This review explores metabolic syndrome (MetS) as a risk factor that accelerates aging in retinal neurons and may contribute to the neurodegeneration seen in glaucomatous optic neuropathy (GON) and age-related macular degeneration (AMD). RECENT FI …
PURPOSE OF REVIEW: This review explores metabolic syndrome (MetS) as a risk factor that accelerates aging in retinal neurons and may contrib …
Nutritional supplementation and age-related macular degeneration.
Olson JH, Erie JC, Bakri SJ. Olson JH, et al. Semin Ophthalmol. 2011 May;26(3):131-6. doi: 10.3109/08820538.2011.577131. Semin Ophthalmol. 2011. PMID: 21609225 Review.
The prevalence of Age-related macular degeneration (AMD) is increasing as the population of elderly in the United States grows. ...This review examines the most current literature available exploring nutritional supplementation in age-related macular degen …
The prevalence of Age-related macular degeneration (AMD) is increasing as the population of elderly in the United States grows …
Current perspectives on ranibizumab.
Dedania VS, Bakri SJ. Dedania VS, et al. Clin Ophthalmol. 2015 Mar 20;9:533-42. doi: 10.2147/OPTH.S80049. eCollection 2015. Clin Ophthalmol. 2015. PMID: 25848203 Free PMC article. Review.
BACKGROUND: This review summarizes the Phase III studies addressing intravitreal ranibizumab treatment in patients with neovascular age-related macular degeneration (AMD), macular edema (ME) from retinal vein occlusion (RVO), and diabetic ME (DME). ...
BACKGROUND: This review summarizes the Phase III studies addressing intravitreal ranibizumab treatment in patients with neovascular age-rela …
Vitreomacular traction and age-related macular degeneration.
Green-Simms AE, Bakri SJ. Green-Simms AE, et al. Semin Ophthalmol. 2011 May;26(3):137-8. doi: 10.3109/08820538.2011.559512. Semin Ophthalmol. 2011. PMID: 21609226 Review.
Recent studies have focused on the vitreo-retinal interface in the context of age-related macular degeneration (AMD), linking vitreo-retinal adhesion to exudative AMD in particular. ...
Recent studies have focused on the vitreo-retinal interface in the context of age-related macular degeneration (AMD), linking …
Mimickers of age-related macular degeneration.
Dosunmu EO, Bakri SJ. Dosunmu EO, et al. Semin Ophthalmol. 2011 May;26(3):209-15. doi: 10.3109/08820538.2011.577134. Semin Ophthalmol. 2011. PMID: 21609234 Review.
In the Western World, the leading cause of irreversible blindness is Age- Related Macular Degeneration (ARMD). It can have significant visual impairment, and it is important that the practicing ophthalmologist is knowledgeable in the diagnosis and treatment of ARMD. …
In the Western World, the leading cause of irreversible blindness is Age- Related Macular Degeneration (ARMD). It can have sig …
Longitudinal Retinal Changes in MOGAD.
Oertel FC, Sotirchos ES, Zimmermann HG, Motamedi S, Specovius S, Asseyer ES, Chien C, Cook L, Vasileiou E, Filippatou A, Calabresi PA, Saidha S, Pandit L, D'Cunha A, Outteryck O, Zéphir H, Pittock S, Flanagan EP, Bhatti MT, Rommer PS, Bsteh G, Zrzavy T, Kuempfel T, Aktas O, Ringelstein M, Albrecht P, Ayzenberg I, Pakeerathan T, Knier B, Aly L, Asgari N, Soelberg K, Marignier R, Tilikete CF, Cobo Calvo A, Villoslada P, Sanchez-Dalmau B, Martinez-Lapiscina EH, Llufriu S, Green AJ, Yeaman MR, Smith TJ, Brandt AU, Chen J, Paul F, Havla J; with the GJCF International Clinical Consortium for NMOSD and the CROCTINO study group. Oertel FC, et al. Ann Neurol. 2022 Sep;92(3):476-485. doi: 10.1002/ana.26440. Epub 2022 Jul 16. Ann Neurol. 2022. PMID: 35703428
OCT data was acquired with (1) Spectralis spectral domain OCT (MOGAD: N = 66 and HCs: N = 103) and (2) Cirrus high-definition OCT (MOGAD: N = 14 and HCs: N = 36). Macular combined ganglion cell and inner plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer ( …
OCT data was acquired with (1) Spectralis spectral domain OCT (MOGAD: N = 66 and HCs: N = 103) and (2) Cirrus high-definition OCT (MOGAD: N …
Novel pharmacotherapies in diabetic retinopathy.
Dedania VS, Bakri SJ. Dedania VS, et al. Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):164-73. doi: 10.4103/0974-9233.154389. Middle East Afr J Ophthalmol. 2015. PMID: 25949073 Free PMC article. Review.
190 results